Clinical Trials · NCT02049034

Lixisenatide-The Effects on Glucose and Lipid Metabolism in Type 2 Diabetes

CompletedPhase 4Lixisenatide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
University of Surrey
Enrollment
8
Start date
Jan 2014
Locations
1 site, United Kingdom
Primary endpoint
Postprandial glucose kinetics
View Lixisenatide compound reference